RC
Resolute Capital Asset Partners LLC
13F filer · CIK 0001834913Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$234MU.S. long equity reported on 13F
Positions4824 new · 17 closed
Net flow last quarter+$17.3MBuys minus sells
Top 10 positions weight50.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202648 positions | |||||
| $31.6M | 13.52% | 0.19% | +20.3% | Q1 2022 | |
| $17.9M | 7.63% | 0.77% | -3.3% | Q3 2025 | |
| $13.1M | 5.60% | 0.00% | +60.2% | Q4 2021 | |
| $11.1M | 4.76% | 0.02% | New | Q2 2026 | |
| $8.03M | 3.43% | 0.01% | Not reported | Q2 2022 | |
| $7.66M | 3.27% | 0.03% | -31.4% | Q1 2025 | |
| $7.53M | 3.22% | 0.07% | Not reported | Q3 2024 | |
| $7.47M | 3.19% | 0.05% | +25.0% | Q1 2026 | |
| $6.94M | 2.97% | 0.08% | +36.0% | Q1 2026 | |
| $6.79M | 2.90% | 0.23% | New | Q2 2026 | |
| $5.62M | 2.40% | 0.01% | +106.5% | Q4 2024 | |
| $5.54M | 2.37% | 0.00% | Not reported | Q4 2021 | |
| $5.19M | 2.22% | 0.06% | +11.8% | Q4 2025 | |
| $5.19M | 2.22% | 0.22% | +70.1% | Q2 2024 | |
| $5.04M | 2.15% | 0.17% | New | Q2 2026 | |
| $4.94M | 2.11% | 0.10% | +66.7% | Q2 2025 | |
| $4.87M | 2.08% | 0.08% | New | Q2 2026 | |
| $4.54M | 1.94% | 0.14% | -9.8% | Q1 2026 | |
| $4.33M | 1.85% | 0.00% | Not reported | Q4 2023 | |
| $3.72M | 1.59% | 0.00% | Not reported | Q1 2026 | |
| $3.63M | 1.55% | Not reported | +39.5% | Q1 2026 | |
| $3.53M | 1.51% | 0.01% | Not reported | Q4 2024 | |
| $3.51M | 1.50% | 0.05% | New | Q2 2026 | |
| $3.35M | 1.43% | 0.03% | -14.3% | Q4 2023 | |
| $3.2M | 1.37% | 0.01% | -20.0% | Q4 2025 | |
| $3.18M | 1.36% | 0.02% | -16.7% | Q4 2021 | |
| $3.18M | 1.36% | 0.06% | New | Q2 2026 | |
| $3.17M | 1.36% | 0.01% | -33.3% | Q1 2024 | |
| $3.14M | 1.34% | 0.06% | Not reported | Q3 2025 | |
| $2.92M | 1.25% | 0.01% | -55.6% | Q2 2025 | |
| $2.8M | 1.19% | 0.03% | New | Q2 2026 | |
| $2.79M | 1.19% | 0.00% | Not reported | Q4 2021 | |
| $2.77M | 1.18% | 0.00% | -64.7% | Q4 2021 | |
| $2.5M | 1.07% | 0.04% | New | Q2 2026 | |
| $2.46M | 1.05% | 0.14% | New | Q2 2026 | |
| $2.4M | 1.03% | 0.03% | -41.7% | Q3 2025 | |
| $2.33M | 1.00% | 0.02% | Not reported | Q3 2025 | |
| $2.08M | 0.89% | 0.00% | Not reported | Q1 2022 | |
| $2.04M | 0.87% | 0.00% | Not reported | Q1 2022 | |
| $2M | 0.86% | 0.08% | -48.6% | Q1 2026 | |
| $1.95M | 0.83% | 0.01% | Not reported | Q1 2022 | |
| $1.87M | 0.80% | 0.00% | New | Q2 2026 | |
| $1.84M | 0.79% | 0.00% | Not reported | Q1 2026 | |
| $1.38M | 0.59% | 0.15% | Not reported | Q4 2022 | |
| $1.3M | 0.56% | 2500000.00% | New | Q2 2026 | |
| $892K | 0.38% | 0.03% | New | Q2 2026 | |
| $590K | 0.25% | 0.06% | New | Q2 2026 | |
| $163K | 0.07% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 15, 202641 positions | |||||
| $22.6M | 11.87% | 0.16% | +11.3% | Q1 2022 | |
| $19.4M | 10.20% | 0.80% | +3.9% | Q3 2025 | |
| $12.1M | 6.37% | 0.04% | -44.0% | Q1 2025 | |
| $7.99M | 4.20% | 0.00% | +54.6% | Q4 2021 | |
| $7.15M | 3.76% | 0.00% | -51.7% | Q4 2021 | |
| $6.58M | 3.46% | 0.02% | +80.0% | Q2 2025 | |
| $6.1M | 3.21% | 0.00% | New | Q1 2026 | |
| $5.93M | 3.12% | 0.02% | New | Q1 2026 | |
| $5.73M | 3.02% | 0.04% | New | Q1 2026 | |
| $5.59M | 2.94% | 0.01% | Not reported | Q2 2022 | |
| $5.26M | 2.77% | 0.05% | Not reported | Q4 2025 | |
| $5.17M | 2.72% | 0.00% | +150.0% | Q1 2022 | |
| $4.53M | 2.38% | 0.16% | New | Q1 2026 | |
| $4.51M | 2.37% | 0.01% | +50.0% | Q1 2024 | |
| $4.24M | 2.23% | 0.00% | New | Q1 2026 | |
| $4.23M | 2.22% | 0.01% | +17.7% | Q4 2024 | |
| $4.2M | 2.21% | 0.01% | +7.1% | Q4 2025 | |
| $4.1M | 2.16% | 0.00% | Not reported | Q2 2023 | |
| $3.94M | 2.07% | 0.02% | Not reported | Q3 2025 | |
| $3.81M | 2.01% | 0.16% | New | Q1 2026 | |
| $3.65M | 1.92% | 0.02% | -21.7% | Q4 2021 | |
| $3.64M | 1.91% | 0.00% | New | Q1 2026 | |
| $3.62M | 1.90% | 0.06% | +33.3% | Q3 2025 | |
| $3.37M | 1.77% | 0.06% | New | Q1 2026 | |
| $3.28M | 1.73% | 0.08% | -40.0% | Q1 2024 | |
| $3.08M | 1.62% | 0.00% | Not reported | Q4 2021 | |
| $2.99M | 1.57% | 0.03% | -41.7% | Q4 2023 | |
| $2.95M | 1.55% | 0.06% | New | Q1 2026 | |
| $2.57M | 1.35% | 0.13% | -20.8% | Q2 2024 | |
| $2.53M | 1.33% | 0.06% | Not reported | Q2 2025 | |
| $2.44M | 1.28% | 0.04% | Not reported | Q4 2024 | |
| $1.95M | 1.03% | 0.27% | Not reported | Q4 2021 | |
| $1.92M | 1.01% | 0.00% | New | Q1 2026 | |
| $1.91M | 1.00% | 0.01% | -70.0% | Q4 2025 | |
| $1.89M | 1.00% | 0.00% | New | Q1 2026 | |
| $1.84M | 0.97% | 0.01% | Not reported | Q4 2024 | |
| $1.36M | 0.72% | Not reported | New | Q1 2026 | |
| $762K | 0.40% | 0.01% | New | Q1 2026 | |
| $613K | 0.32% | 0.02% | Not reported | Q3 2025 | |
| $353K | 0.19% | 0.05% | New | Q1 2026 | |
| $261K | 0.14% | 0.29% | Not reported | Q4 2025 | |
| Q4 2025Reported Feb 17, 202649 positions | |||||
| $18.9M | 9.13% | 0.14% | -46.5% | Q1 2022 | |
| $16.4M | 7.94% | 0.00% | +77.9% | Q4 2021 | |
| $13.8M | 6.68% | 0.77% | +1200.0% | Q3 2025 | |
| $13.1M | 6.31% | 0.07% | Not reported | Q1 2025 | |
| $9.41M | 4.55% | Not reported | Not reported | Q4 2021 | |
| $8.77M | 4.24% | 0.08% | +62.5% | Q3 2025 | |
| CTCDTXCidara Therapeutics, Inc. | $8.24M | 3.98% | 0.12% | -34.9% | Q2 2025 |
| $6.8M | 3.29% | 0.07% | New | Q4 2025 | |
| $6.36M | 3.07% | 0.05% | -27.2% | Q3 2025 | |
| $5.79M | 2.80% | 0.00% | -33.3% | Q3 2025 | |
| $5.53M | 2.67% | 0.05% | Not reported | Q4 2023 | |
| $5.5M | 2.65% | 0.00% | -31.3% | Q4 2021 | |
| $4.7M | 2.27% | 0.01% | -33.3% | Q3 2025 | |
| $4.58M | 2.21% | 0.00% | Not reported | Q3 2023 | |
| $4.57M | 2.21% | 0.07% | New | Q4 2025 | |
| $4.45M | 2.15% | 0.03% | New | Q4 2025 | |
| $4.4M | 2.13% | 0.03% | +15.0% | Q4 2021 | |
| $4.14M | 2.00% | 0.13% | Not reported | Q1 2024 | |
| $4.13M | 2.00% | 0.05% | +8.3% | Q3 2025 | |
| $3.98M | 1.92% | 0.01% | -28.6% | Q2 2025 | |
| $3.79M | 1.83% | 0.01% | New | Q4 2025 | |
| $3.73M | 1.80% | 0.01% | Not reported | Q2 2024 | |
| $3.31M | 1.60% | 0.06% | Not reported | Q1 2024 | |
| $3.23M | 1.56% | 0.01% | Not reported | Q1 2024 | |
| $3.15M | 1.52% | 0.02% | Not reported | Q3 2025 | |
| $3.06M | 1.48% | 0.05% | New | Q4 2025 | |
| $3.02M | 1.46% | 0.01% | Not reported | Q4 2024 | |
| $2.76M | 1.34% | 0.04% | -35.7% | Q3 2025 | |
| $2.71M | 1.31% | 0.13% | New | Q4 2025 | |
| $2.6M | 1.26% | 0.00% | New | Q4 2025 | |
| $2.35M | 1.14% | 0.16% | Not reported | Q2 2024 | |
| $2.22M | 1.07% | 0.01% | New | Q4 2025 | |
| $2.13M | 1.03% | 0.00% | New | Q4 2025 | |
| $2.03M | 0.98% | 0.03% | New | Q4 2025 | |
| $1.85M | 0.90% | 0.03% | -16.3% | Q2 2025 | |
| $1.7M | 0.82% | 0.22% | Not reported | Q4 2022 | |
| $1.52M | 0.74% | 0.00% | -33.3% | Q1 2022 | |
| $1.45M | 0.70% | Not reported | -48.8% | Q2 2025 | |
| $1.33M | 0.64% | 0.16% | New | Q4 2025 | |
| $1.01M | 0.49% | 0.05% | -33.2% | Q3 2025 | |
| $940K | 0.45% | 0.25% | New | Q4 2025 | |
| $785K | 0.38% | 0.06% | New | Q4 2025 | |
| $496K | 0.24% | 0.14% | Not reported | Q2 2025 | |
| $460K | 0.22% | 0.01% | New | Q4 2025 | |
| $433K | 0.21% | 0.06% | New | Q4 2025 | |
| $379K | 0.18% | 0.03% | -83.3% | Q3 2025 | |
| $348K | 0.17% | 0.29% | New | Q4 2025 | |
| $326K | 0.16% | 0.07% | New | Q4 2025 | |
| $268K | 0.13% | 0.04% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202544 positions | |||||
| $32.9M | 17.23% | 0.27% | +3.1% | Q1 2022 | |
| $8.78M | 4.59% | 0.00% | -19.9% | Q4 2021 | |
| $7.64M | 4.00% | 0.00% | +119.8% | Q4 2021 | |
| $7.4M | 3.87% | 0.01% | New | Q3 2025 | |
| $7.31M | 3.82% | Not reported | Not reported | Q4 2021 | |
| $7.28M | 3.81% | 0.00% | New | Q3 2025 | |
| $7.15M | 3.74% | 0.00% | Not reported | Q1 2022 | |
| $6.88M | 3.60% | 0.07% | New | Q3 2025 | |
| $6.28M | 3.29% | 0.14% | +35.2% | Q2 2025 | |
| $5.84M | 3.05% | 0.03% | Not reported | Q2 2023 | |
| $5.67M | 2.97% | 0.02% | -35.9% | Q2 2025 | |
| $5.59M | 2.92% | 0.00% | -60.0% | Q4 2022 | |
| CTCDTXCidara Therapeutics, Inc. | $5.49M | 2.87% | 0.20% | +109.8% | Q2 2025 |
| $5.19M | 2.72% | 0.02% | +16.9% | Q2 2025 | |
| $5.18M | 2.71% | 0.00% | Not reported | Q1 2022 | |
| $5.06M | 2.65% | 0.01% | -17.6% | Q2 2025 | |
| $4.5M | 2.35% | 0.07% | New | Q3 2025 | |
| $3.54M | 1.85% | 0.00% | Not reported | Q2 2023 | |
| $3.44M | 1.80% | 0.02% | -33.4% | Q4 2021 | |
| $3.4M | 1.78% | 0.06% | New | Q3 2025 | |
| $3.3M | 1.72% | 0.05% | New | Q3 2025 | |
| $3.24M | 1.69% | 0.00% | Not reported | Q4 2023 | |
| $3.07M | 1.61% | 0.01% | +54.9% | Q4 2024 | |
| $2.84M | 1.48% | Not reported | -0.4% | Q2 2025 | |
| $2.77M | 1.45% | Not reported | Not reported | Q1 2023 | |
| $2.46M | 1.28% | 0.02% | New | Q3 2025 | |
| $2.33M | 1.22% | 0.00% | Not reported | Q1 2022 | |
| $2.13M | 1.12% | 0.08% | Not reported | Q3 2023 | |
| $2.06M | 1.08% | 0.01% | New | Q3 2025 | |
| $2.01M | 1.05% | 0.17% | -26.4% | Q2 2025 | |
| $1.99M | 1.04% | 0.07% | New | Q3 2025 | |
| $1.88M | 0.98% | 0.04% | -49.3% | Q2 2025 | |
| $1.83M | 0.96% | 0.07% | New | Q3 2025 | |
| $1.83M | 0.96% | 0.04% | New | Q3 2025 | |
| $1.73M | 0.90% | 0.02% | New | Q3 2025 | |
| $1.68M | 0.88% | 0.08% | New | Q3 2025 | |
| $1.67M | 0.87% | Not reported | +35.5% | Q1 2025 | |
| $1.52M | 0.79% | 0.05% | New | Q3 2025 | |
| $1.44M | 0.75% | 0.16% | New | Q3 2025 | |
| $1.31M | 0.68% | 0.01% | New | Q3 2025 | |
| $1.17M | 0.61% | 0.03% | New | Q3 2025 | |
| $1.01M | 0.53% | 0.01% | -39.2% | Q3 2024 | |
| $796K | 0.42% | 0.06% | New | Q3 2025 | |
| $562K | 0.29% | 0.14% | Not reported | Q2 2025 | |
Premium opens every quarter this fund has filed